FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2580051187> ?p ?o ?g. }

• W2580051187 endingPage "3928" @default.
• W2580051187 startingPage "3919" @default.
• W2580051187 abstract "Increasing lines of evidence support the causal link between α-synuclein (α-syn) accumulation in the brain and Parkinson's disease (PD) pathogenesis. Therefore, lowering α-syn protein levels may represent a viable therapeutic strategy for the treatment of PD and related disorders. We recently described a novel selective α-syn degradation pathway, catalyzed by the activity of the Polo-like kinase 2 (PLK2), capable of reducing α-syn protein expression and suppressing its toxicity in vivo. However, the exact molecular mechanisms underlying this degradation route remain elusive. In the present study we report that among PLK family members, PLK3 is also able to catalyze α-syn phosphorylation and degradation in living cells. Using pharmacological and genetic approaches, we confirmed the implication of the macroautophagy on PLK2-mediated α-syn turnover, and our observations suggest a concomitant co-degradation of these two proteins. Moreover, we showed that the N-terminal region of α-syn is important for PLK2-mediated α-syn phosphorylation and degradation and is implicated in the physical interaction between the two proteins. We also demonstrated that PLK2 polyubiquitination is important for PLK2·α-syn protein complex degradation, and we hypothesize that this post-translational modification may act as a signal for the selective recognition by the macroautophagy machinery. Finally, we observed that the PD-linked mutation E46K enhances PLK2-mediated α-syn degradation, suggesting that this mutated form is a bona fide substrate of this degradation pathway. In conclusion, our study provides a detailed description of the new degradation route of α-syn and offers new opportunities for the development of therapeutic strategies aiming to reduce α-syn protein accumulation and toxicity. Increasing lines of evidence support the causal link between α-synuclein (α-syn) accumulation in the brain and Parkinson's disease (PD) pathogenesis. Therefore, lowering α-syn protein levels may represent a viable therapeutic strategy for the treatment of PD and related disorders. We recently described a novel selective α-syn degradation pathway, catalyzed by the activity of the Polo-like kinase 2 (PLK2), capable of reducing α-syn protein expression and suppressing its toxicity in vivo. However, the exact molecular mechanisms underlying this degradation route remain elusive. In the present study we report that among PLK family members, PLK3 is also able to catalyze α-syn phosphorylation and degradation in living cells. Using pharmacological and genetic approaches, we confirmed the implication of the macroautophagy on PLK2-mediated α-syn turnover, and our observations suggest a concomitant co-degradation of these two proteins. Moreover, we showed that the N-terminal region of α-syn is important for PLK2-mediated α-syn phosphorylation and degradation and is implicated in the physical interaction between the two proteins. We also demonstrated that PLK2 polyubiquitination is important for PLK2·α-syn protein complex degradation, and we hypothesize that this post-translational modification may act as a signal for the selective recognition by the macroautophagy machinery. Finally, we observed that the PD-linked mutation E46K enhances PLK2-mediated α-syn degradation, suggesting that this mutated form is a bona fide substrate of this degradation pathway. In conclusion, our study provides a detailed description of the new degradation route of α-syn and offers new opportunities for the development of therapeutic strategies aiming to reduce α-syn protein accumulation and toxicity." @default.
• W2580051187 created "2017-02-03" @default.
• W2580051187 creator A5036504758 @default.
• W2580051187 creator A5051197803 @default.
• W2580051187 creator A5068155611 @default.
• W2580051187 date "2017-03-01" @default.
• W2580051187 modified "2023-09-27" @default.
• W2580051187 title "Dissecting the Molecular Pathway Involved in PLK2 Kinase-mediated α-Synuclein-selective Autophagic Degradation" @default.
• W2580051187 cites W1518893426 @default.
• W2580051187 cites W1527671059 @default.
• W2580051187 cites W1637321639 @default.
• W2580051187 cites W1860081569 @default.
• W2580051187 cites W1971128969 @default.
• W2580051187 cites W1979591162 @default.
• W2580051187 cites W1979786105 @default.
• W2580051187 cites W1981172305 @default.
• W2580051187 cites W1982732854 @default.
• W2580051187 cites W1986941385 @default.
• W2580051187 cites W1992241406 @default.
• W2580051187 cites W1994696750 @default.
• W2580051187 cites W1997597731 @default.
• W2580051187 cites W2008665417 @default.
• W2580051187 cites W2016715304 @default.
• W2580051187 cites W2018359045 @default.
• W2580051187 cites W2018636808 @default.
• W2580051187 cites W2023875044 @default.
• W2580051187 cites W2026982903 @default.
• W2580051187 cites W2027096397 @default.
• W2580051187 cites W2031964854 @default.
• W2580051187 cites W2032797457 @default.
• W2580051187 cites W2044085158 @default.
• W2580051187 cites W2045489211 @default.
• W2580051187 cites W2048494900 @default.
• W2580051187 cites W2063834181 @default.
• W2580051187 cites W2066594212 @default.
• W2580051187 cites W2068288454 @default.
• W2580051187 cites W2072992526 @default.
• W2580051187 cites W2078708066 @default.
• W2580051187 cites W2079438044 @default.
• W2580051187 cites W2079481706 @default.
• W2580051187 cites W2084970853 @default.
• W2580051187 cites W2092765043 @default.
• W2580051187 cites W2099002508 @default.
• W2580051187 cites W2100434800 @default.
• W2580051187 cites W2105249930 @default.
• W2580051187 cites W2107611874 @default.
• W2580051187 cites W2117626437 @default.
• W2580051187 cites W2118369622 @default.
• W2580051187 cites W2123637726 @default.
• W2580051187 cites W2124975942 @default.
• W2580051187 cites W2127342428 @default.
• W2580051187 cites W2133578402 @default.
• W2580051187 cites W2140664473 @default.
• W2580051187 cites W2144435948 @default.
• W2580051187 cites W2149985689 @default.
• W2580051187 cites W2155612332 @default.
• W2580051187 cites W2157535220 @default.
• W2580051187 cites W2163326936 @default.
• W2580051187 cites W2167390229 @default.
• W2580051187 cites W62603772 @default.
• W2580051187 doi "https://doi.org/10.1074/jbc.m116.759373" @default.
• W2580051187 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5339772" @default.
• W2580051187 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28154193" @default.
• W2580051187 hasPublicationYear "2017" @default.
• W2580051187 type Work @default.
• W2580051187 sameAs 2580051187 @default.
• W2580051187 citedByCount "21" @default.
• W2580051187 countsByYear W25800511872017 @default.
• W2580051187 countsByYear W25800511872018 @default.
• W2580051187 countsByYear W25800511872019 @default.
• W2580051187 countsByYear W25800511872020 @default.
• W2580051187 countsByYear W25800511872021 @default.
• W2580051187 countsByYear W25800511872022 @default.
• W2580051187 countsByYear W25800511872023 @default.
• W2580051187 crossrefType "journal-article" @default.
• W2580051187 hasAuthorship W2580051187A5036504758 @default.
• W2580051187 hasAuthorship W2580051187A5051197803 @default.
• W2580051187 hasAuthorship W2580051187A5068155611 @default.
• W2580051187 hasBestOaLocation W25800511871 @default.
• W2580051187 hasConcept C104317684 @default.
• W2580051187 hasConcept C11960822 @default.
• W2580051187 hasConcept C184235292 @default.
• W2580051187 hasConcept C185592680 @default.
• W2580051187 hasConcept C190283241 @default.
• W2580051187 hasConcept C203522944 @default.
• W2580051187 hasConcept C25602115 @default.
• W2580051187 hasConcept C2992195973 @default.
• W2580051187 hasConcept C501734568 @default.
• W2580051187 hasConcept C55493867 @default.
• W2580051187 hasConcept C86803240 @default.
• W2580051187 hasConcept C95444343 @default.
• W2580051187 hasConceptScore W2580051187C104317684 @default.
• W2580051187 hasConceptScore W2580051187C11960822 @default.
• W2580051187 hasConceptScore W2580051187C184235292 @default.
• W2580051187 hasConceptScore W2580051187C185592680 @default.
• W2580051187 hasConceptScore W2580051187C190283241 @default.
• W2580051187 hasConceptScore W2580051187C203522944 @default.
• W2580051187 hasConceptScore W2580051187C25602115 @default.

• next